1. Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy

   • R. Yang
   • H. Dong
   • Z. Yang

   Review Article 17 January 2022 Pages: 1219 - 1230

   

2. Platelets for cancer treatment and drug delivery

   • Gaozhe Xiao
   • Zhikun Zhang
   • Jian He

   Review Article 26 February 2022 Pages: 1231 - 1237

   

3. Emerging roles of JMJD3 in cancer

   • Maryam Farzaneh
   • Zeinab Kuchaki
   • Omid Anbiyaee

   Review Article 03 March 2022 Pages: 1238 - 1249

   

4. The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML

   • Shohre Karimi Kelaye
   • Fatemeh Najafi
   • Mohammad-Reza Alivand

   Review Article 25 January 2022 Pages: 1250 - 1261

   

5. Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors

   • Nada K. Sedky
   • Alyaa A. Hamdan
   • Mai F. Tolba

   Review Article 23 January 2022 Pages: 1262 - 1273

   

6. The role of EphA7 in different tumors

   • Xiangyi Chen
   • Dechen Yu
   • Kun Zhang

   Review Article 02 February 2022 Pages: 1274 - 1289

   

7. Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer

   • J. Orcajo-Rincon
   • J. Muñoz-Langa
   • A. Luna

   Special Article Open access 13 February 2022 Pages: 1290 - 1310

   

8. MARCH1 silencing suppresses growth of oral squamous cell carcinoma through regulation of PHLPP2

   • L. Liu
   • B. Guo
   • S. Liu

   Research Article 05 February 2022 Pages: 1311 - 1321

   

9. RENORT: a project to analyze patterns of care in radiation oncology in Spain

   • J. López-Torrecilla
   • A. Palacios Eito
   • A. Rodríguez Pérez

   Research Article 13 January 2022 Pages: 1322 - 1332

   

10. Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents

    • Chuanzhen Cao
    • Xiaomei Lan
    • Jianzhong Shou

    Research Article Open access 03 February 2022 Pages: 1333 - 1346

    

11. Comparison of postoperative complication rates between a novel endoluminal balloon-assisted drainage and diverting stoma after low rectal cancer

    • W. Liang
    • H. Jie
    • L. Kang

    Research Article 14 January 2022 Pages: 1347 - 1353

    

12. Cytokine-driven positive feedback loop organizes fibroblast transformation and facilitates gastric cancer progression

    • Xian-Kui Cao
    • Bin Xie
    • Jie Lin

    Research Article 18 March 2022 Pages: 1354 - 1364

    

13. Identification of the function of γδ1 T cells in the lung cancer microenvironments

    • W. Sun
    • H. Yang
    • C. Ma

    Research Article 29 January 2022 Pages: 1365 - 1371

    

14. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia

    • Fatemeh Memari
    • Vahid Tavakolpour
    • Nosratollah Zarghami

    Research Article 05 March 2022 Pages: 1372 - 1380

    

15. A novel immune-related RNA-binding proteins signature to predict survival and therapeutic responses in prostate cancer

    • Zicheng Wang
    • Yifei Zhang
    • Binbin Gong

    Research Article 10 February 2022 Pages: 1381 - 1394

    

16. Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer

    • M. Loi
    • G. Salvatore
    • L. Livi

    Research Article 25 February 2022 Pages: 1395 - 1402

    

17. Autophagy deficiency promotes lung metastasis of prostate cancer via stabilization of TWIST1

    • Y. X. Shi
    • Z. W. Sun
    • H. B. Wang

    Research Article 08 February 2022 Pages: 1403 - 1412

    

18. RNA modification “writer”-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer

    • Yanjun Qu
    • Hong Zhu
    • Dandan Yuan

    Research Article 27 February 2022 Pages: 1413 - 1424

    

19. Radiotherapy-related toxicity for localized prostate cancer: meta-analysis comparing conventional or moderately hypofractionated vs. ultrahypofractionated protocols

    • Willy Baccaglini
    • Icaro T. de Carvalho
    • Sidney Glina

    Research Article 04 March 2022 Pages: 1425 - 1439

    

20. Assessing the tumor immune microenvironment in gastric carcinoma: a practical approach

    • H. Abushukair
    • A. Saeed

    Correspondence 02 February 2022 Pages: 1440 - 1441

21. Correction to: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021)

    • Margarita Majem
    • Ramon de las Peñas
    • Yolanda Escobar

    Correction Open access 14 May 2022 Pages: 1442 - 1442

22. Correction to: SEOM‑GEMCAD‑TTD clinical guidelines for localized rectal cancer (2021)

    • Jaume Capdevila
    • Ma Auxiliadora Gómez
    • Javier Sastre

    Correction Open access 20 May 2022 Pages: 1443 - 1444

    

23. Correction to: Nivolumab treatment beyond progressive disease in advanced non‑small cell lung cancer

    • Takatoshi Enomoto
    • Akihiro Tamiya
    • Shinji Atagi

    Correction 22 February 2022 Pages: 1445 - 1445